Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback